1. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art

   • Frank Roossink
   • Steven de Jong
   • Ed Schuuring

   Review 27 July 2012 Pages: 231 - 241

   

2. Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines

   • Annemarie Koch
   • Jiri Hatina
   • Wolfgang A. Schulz

   Original Paper 06 June 2012 Pages: 243 - 257

   

3. Hypomethylation of LINE-1, and not centromeric SAT-α, is associated with centromeric instability in head and neck squamous cell carcinoma

   • Jorge García Martínez
   • Jhudit Pérez-Escuredo
   • Mario A. Hermsen

   Original Paper 21 June 2012 Pages: 259 - 267

   

4. Myrtenal attenuates diethylnitrosamine-induced hepatocellular carcinoma in rats by stabilizing intrinsic antioxidants and modulating apoptotic and anti-apoptotic cascades

   • Lingaiah Hari Babu
   • Srinivasan Perumal
   • Maruthaiveeran Periyasamy Balasubramanian

   Original Paper 22 June 2012 Pages: 269 - 283

   

5. miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors

   • Marina Gonçalves Diniz
   • Carolina Cavaliéri Gomes
   • Ricardo Santiago Gomez

   Original Paper 09 June 2012 Pages: 285 - 291

   

6. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression

   • Anke H. Sillars-Hardebol
   • Beatriz Carvalho
   • Remond J. A. Fijneman

   Original Paper Open access 19 June 2012 Pages: 293 - 300

   

7. Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours

   • Victoria J. Cookson
   • Michael A. Bentley
   • Thomas A. Hughes

   Original Paper 21 July 2012 Pages: 301 - 308

8. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection

   • Linda J. W. Bosch
   • Sandra Mongera
   • Gerrit A. Meijer

   Original Paper 21 July 2012 Pages: 309 - 315